InSite reports second quarter net income of $12.1 million

After a loss of $6.8 million in the second quarter of 2012, InSite Vision has reported a net income of $12.1 million for the second quarter of 2013, according to a company news release.The increase is largely attributable to InSite’s sale of royalty rights to Besivance (besifloxacin ophthalmic suspension 0.6%) for $15 million.

Aging Is Not a Disease: Distinguishing Age-Related Macular Degeneration from Aging

Publication date: Available online 9 August 2013
Source:Progress in Retinal and Eye Research
Author(s): Daniel Ardeljan , Chi-Chao Chan
Age-related macular degeneration (AMD) is a disease of the outer retina, characterized most significantly by atrophy of photoreceptors and retinal pigment epithelium accompanied with or without choroidal neovascularization. Development of (Read more...)